Osteosarcoma
Diagnosis certain
Disclosures
- updated 6 Apr 2022:
- Radiopaedia Events Pty Ltd, Speaker fees (past)
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
Updates to Case Attributes
Status
changed from pending review to published (public).
Published At
was set to
.
Presentation
was changed:
Age
changed from 13 to 13 years.
Systems changed:
- Oncology